PURPOSE: To detect the defects of insulin promoter and upstream promoter transcription factor (COUP-TF) by bonding antibody bonded to at least one antigen site of biological sample and COUP-TF.
CONSTITUTION: A biological sample is bonded to antibody bonded to at least one antigen site of COUP-TF. The sample/antibody mixture is measured for the antibody bond, and the coup-TF in the sample is measured. The antibody/ COUP-TF complex formed by bonding the antibody to the sample is measured. The COUP-TF is bonded to the nucleus extract obtained from the sample, the bonding amount of the COUP-TF promoter is measured, and the COUP-TF promoter is measured. Further, COUP-TF oligonucleotide is bonded to the sample, the formed COUP oligonucleotide complex amount is measured, and the original COUP-TF bondability in the sample is measured.
JP2006517092 | Heart failure gene determination and therapeutic drug screening |
JP2010535503 | VHZ for diagnosis and treatment of cancer |
JPH06269293 | MONOCLONAL ANTIBODY TO MURINE CD48 |
MINGUUJIYAA TSUAI
RII-HOU WAN
SOFUIA YAN TSUAI
Next Patent: CONTROLLER FOR CONTROLLING SUCTION TUBE OF AUTOMATIC SAMPLE DISPENSER